Drug Shortage Report for APO-PERINDOPRIL-INDAPAMIDE
Report ID | 184092 |
Drug Identification Number | 02297574 |
Brand name | APO-PERINDOPRIL-INDAPAMIDE |
Common or Proper name | PERINDOPRIL-INDAPAMIDE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | INDAPAMIDE PERINDOPRIL ERBUMINE |
Strength(s) | 1.25MG 4MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-07 |
Estimated end date | 2023-09-22 |
Actual end date | 2023-09-15 |
Shortage status | Resolved |
Updated date | 2023-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v45 | 2023-09-22 | French | Compare |
v44 | 2023-09-22 | English | Compare |
v43 | 2023-09-07 | French | Compare |
v42 | 2023-09-07 | English | Compare |
v41 | 2023-09-01 | French | Compare |
v40 | 2023-09-01 | English | Compare |
v39 | 2023-08-04 | French | Compare |
v38 | 2023-08-04 | English | Compare |
v37 | 2023-07-21 | French | Compare |
v36 | 2023-07-21 | English | Compare |
v35 | 2023-07-21 | English | Compare |
v34 | 2023-07-13 | French | Compare |
v33 | 2023-07-13 | English | Compare |
v32 | 2023-07-07 | French | Compare |
v31 | 2023-07-07 | English | Compare |
v30 | 2023-06-29 | French | Compare |
v29 | 2023-06-29 | English | Compare |
v28 | 2023-06-23 | French | Compare |
v27 | 2023-06-23 | English | Compare |
v26 | 2023-06-23 | French | Compare |